Shrimp Disease Diagnostics Market Report Overview
-
Request a Free Sample to learn more about this report
The global shrimp disease diagnostics market size was USD 147.81 million in 2021. As per our research, the market is projected to touch USD 457.07 million in 2031, exhibiting a CAGR of 11.82% during the forecast period.
The global COVID-19 pandemic has been unprecedented and staggering, with shrimp disease diagnostics experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.
Shrimp disease diagnostics is a technology that helps to detect shrimp suffering from any sort of virus.
Increased demand for shrimp for human consumption coupled with growing demand for marine & freshwater farming is the major factor of the market growth. The growing popularity of aqua food habits is predicted to drive market growth. Increased awareness about the consumption of shrimp and demand for high nutrition diet is expected to fuel market growth in the forthcoming years. Further, a rise in awareness of diseases associated with shrimp and digestion problems is anticipated to foster market progress. The growing need for DNA-based diagnostic tools such as PCR and the rapid adoption of technology in the marine and aqua sectors is projected to expand market growth. In addition, the easy availability of test kits in the pharmaceutical is expected to drive market growth. On the contrary, the high cost associated with disease diagnostic technology is predicted to restrict market growth in the forthcoming years.
COVID-19 Impact: Lack of Fishermen due to Lockdown Restrictions to Harm Market Growth
Closure of manufacturing units and lower demand for the technology due to lockdown restrictions. The shutdown of marine and aquaculture laboratories and the lack of fishers due to health safety restrict the market growth.
LATEST TRENDS
"Increased Demand for Seafood Globally to Push Market Growth"
Increasing demand for seafood globally is estimated to fuel market growth. A rise in awareness about the benefits of seafood in diet coupled with a high need for a nutritious diet is predicted to surge market growth. Huge demand for protein-based dirt for muscle gain and an increased number of dietitians refer to seafood for high protein and other several nutritional properties. These factors are estimated to boost technology adoption in the forthcoming years. The growing popularity of aqua food habits is predicted to drive market growth. Increased awareness about the consumption of shrimp and demand for high nutrition diet is expected to fuel shrimp diseases diagnostics market market growth.
Shrimp Disease Diagnostics Market Segmentation
-
Request a Free Sample to learn more about this report
- By Type
Based on type, the market is divided into IHHNV (Infectious Hypodermal and Hematopoietic Virus), MBV (Monodon Baculovirus), WSSV (White Spot Syndrome Virus), HPV (Hepatopancreatic Parvovirus), NHP-B (Necrotising Hepatopancreatitis Bacteria), TSV (Taura Syndrome Virus), YHV/GAV (Yellow Head/Gill, Associated Virus), IMNV (Infectious Myonecrosis Virus), MOV (Mourilyan Virus), and Early Mortality Syndrome (EMS).
WSSV (White Spot Syndrome Virus) is expected to be the top part of the segmentation type.
- By Application
Based on the application, the market is divided into fisheries, aquaculture laboratories, marine laboratories, education and research institutes, and others.
Aquaculture laboratories are expected to be the top part of application segmentation.
DRIVING FACTORS
"Growing need for Shrimp Farming and Huge Production of Shrimps to Surge Market Growth"
Increasing demand for shrimp globally and huge production of shrimp are anticipated to drive market growth. A rise in demand for technology in education and research institutes is projected to contribute to market growth. Increased need to reduce disease prevalence and huge adoption of technology is predicted to surge market growth. Increased spending capacity and growing awareness about health safety are anticipated to accelerate market progress in the forthcoming years. Increased demand for freshwater and marine shrimp farming is expected to fuel market progress.
"Increased Prevalence of Viral Infections in Shrimps to Foster Market Progress"
The growing prevalence of viral infection in shrimps and the high need to detect to control spreading is estimated to fuel market growth. Huge demand to detect shrimp disease and a growing need to improve marine farming methods is anticipated to drive market growth. An increased number of manufacturers are focused on developing PCR base systems and ensuring flexible & real is estimated to drive market growth in the forthcoming years.
RESTRAINING FACTORS
"High Cost of the Technology to Harm Market Progress"
The high cost associated with disease diagnostic technology is predicted to restrict market growth in the forthcoming years.
Shrimp Disease Diagnostics Market Regional Insights
-
Request a Free Sample to learn more about this report
"High Production Rate in Asia Pacific to Drive Market Share "
Asia Pacific is anticipated to dominate the shrimp disease diagnostics market share owing to the high production rate in India and China. Increased government regulation for food safety and huge consumption of shrimp’s consumption. The growing popularity of aqua food habits is predicted to drive market growth. Increased awareness about the consumption of shrimp and demand for high nutrition diet is expected to fuel market growth in the forthcoming years. Further, a rise in awareness of diseases associated with shrimp and digestion problems is anticipated to foster market progress. The growing need for DNA-based diagnostic tools such as PCR and the rapid adoption of technology in the marine and aqua sectors is projected to expand market growth.
KEY INDUSTRY PLAYERS
"Leading Players Adopt New Strategies to Stay Competitive"
The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.
List of Market Players Profiled
- GeneReach Biotechnology Corp. (China)
- REAGEN LLC (U.S.)
- Auro Biotechnologies (India)
- HiMedia Laboratories (India)
- pop bio (U.K.)
- AquaBounty Technologies, Inc. (U.S.)
- Lab - Ind Resource Sdn Bhd. (Malaysia)
- FUJIKURA KASEI CO., LTD. (Japan)
- Thermo Fisher Scientific (U.S.)
- SUREBIO (U.S.)
- Speedy Assay Sdn Bhd (Malaysia)
REPORT COVERAGE
This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 147.81 Million in 2021 |
Market Size Value By |
US$ 457.07 Million by 2031 |
Growth Rate |
CAGR of 11.82% from 2021 to 2031 |
Forecast Period |
2023-2031 |
Base Year |
2022 |
Historical Data Available |
Yes |
Segments Covered |
Type and Application |
Regional Scope |
Global |
Frequently Asked Questions
-
What value is the shrimp disease diagnostics market expected to touch by 2031?
The global shrimp disease diagnostics market size is expected to reach USD 457.07 million in 2031.
-
What CAGR is the shrimp disease diagnostics market expected to exhibit by 2031?
The shrimp disease diagnostics market is expected to exhibit a CAGR of 14.35% by 2031.
-
Which are the driving factors of the shrimp disease diagnostics market?
Drivers of this shrimp disease diagnostics market are growing need for shrimp farming and huge production of shrimps and the increased prevalence of viral infections in shrimps.
-
Which are the top companies operating in the shrimp disease diagnostics market?
GeneReach Biotechnology Corp., REAGEN LLC, Auro Biotechnologies, HiMedia Laboratories pop bio, AquaBounty Technologies, Inc., Lab - Ind Resource Sdn Bhd., FUJIKURA KASEI CO., LTD., Thermo Fisher Scientific, SUREBIO, and Speedy Assay Sdn Bhd are the top companies operating in the shrimp disease diagnostics market.